Creative Biolabs is strengthening its lipid-based delivery portfolio with enhanced lipid nanoparticle (LNP) and liposome engineering capabilities designed to support the growing demand for RNA ...

Formulation complexity, especially in small molecule drugs, has been getting more attention as capabilities continue to ...

Founded earlier this year, JellyFil was established to participate in the growing global market for wellness and nutritional ...

Proven bacterial, viral, conjugate, and E.coli expression platforms support partners from discovery and process development to GMP readiness and clinical manufacturing ...

The startup is focused on developing evidence-based natural and synthetic therapeutics for conditions such as psoriasis, ...

AustinPx, a contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement for orally delivered small molecule drugs, today announced its agreement with Thermo ...

VANCOUVER, BC / ACCESS Newswire / June 23, 2026 / Onco-Innovations Limited (NEO:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered into a ...

Coiled Therapeutics (AIM:COIL, OTCQB:COTXF), a clinical-stage oncology company developing medicines for hard-to-treat cancers ...

New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with ...

An advanced AI platform should help R&D labs streamline workflows while supporting long-term innovation and competitive ...

Ascletis submits two IND applications to the US FDA to treat obesity: ASC36 once-monthly injection & ASC36_35 FDC once-monthly injection: Hong Kong Tuesday, July 7, 2026, 12:00 Hr ...

VANCOUVER, BC / ACCESS Newswire / July 6, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...